LCA5 Antikörper (N-Term)
Kurzübersicht für LCA5 Antikörper (N-Term) (ABIN632308)
Target
Alle LCA5 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- LCA5 antibody was raised against the N terminal of LCA5
-
Aufreinigung
- Affinity purified
-
Immunogen
- LCA5 antibody was raised using the N terminal of LCA5 corresponding to a region with amino acids FSLQKLKEISEARHLPERDDLAKKLVSAELKLDDTERRIKELSKNLELST
-
-
-
-
Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
LCA5 Blocking Peptide, (ABIN938457), is also available for use as a blocking control in assays to test for specificity of this LCA5 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of LCA5 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- LCA5 (Leber Congenital Amaurosis 5 (LCA5))
-
Andere Bezeichnung
- LCA5
-
Hintergrund
- LCA5 is a protein that is thought to be involved in centrosomal or ciliary functions. Mutations in this gene cause Leber congenital amaurosis type V. Mutations in this gene cause Leber congenital amaurosis type V. Alternative splicing results in two transcript variants.
-
Molekulargewicht
- 80 kDa (MW of target protein)
Target
-